20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T21383 | D-Thyroxine | Dethyrona,Detyroxin,Dextroid,Dextrothyroxine;Biotirmone,Dextroxin,Biotirmone,Debetrol,Dextrothyroxine | Others |
D-Thyroxine (Dextroxin) could lower cholesterol and also increases hepatic lipase which in turn improves utilization of triglycerides, leading to improve apolipoprotein E cholesterol particles. | |||
T9920 | Evolocumab | Others | |
Evolocumab is a human IgG2 monoclonal antibody that binds to human PCSK9 Proprotein Convertase Subtilisin Kexin Type 9). | |||
T31611 | Eldacimibe | WAY-ACA-147,UNII-4PBL76O2G8,ANA 147,ACA 147 | Acyltransferase |
Eldacimibe (WAY-ACA-147) is an ACAT2 inhibitor for the treatment of cardiovascular disease and endocrine and metabolic disorders, study of atherosclerosis and hypercholesterolemia. | |||
T4509 | Inositol nicotinate | Inositol niacinate,Hexanicotol,Myo-Inositol hexanicotinate,Mesotal,Dilexpal,Inositol hexanicotinate | Others |
Inositol nicotinate (Mesotal) has the effect of lowering cholesterol and expanding peripheral blood vessels for hypercholesterolemia and atherosclerosis. | |||
T25276 | Crilvastatin | PMD387,PMD 387,PMD-387 | HMG-CoA Reductase |
Crilvastatin (PMD 387) is a novel non-competitive hydroxymethylglutaryl coenzyme A reductase inhibitor with cholesterol-lowering activity that inhibits cholesterol uptake in rats with hereditary hypercholesterolemia. | |||
T2968 | Hyodeoxycholic acid | NSC 60672,α-Hyodeoxycholic Acid,HDCA | FXR , Endogenous Metabolite , GPCR19 |
Hyodeoxycholic acid (NSC 60672) has been used in trials studying the treatment of Hypercholesterolemia. | |||
T27832 | Lifibrol | U 83860,K-12148,K-12.148,U-83860,K12148 | Lipid |
Lifibrol (U-83860) is an inhibitor of cholesterol synthesis.Lifibrol has anticholesterol and hypolipidemic properties and promotes the conversion of LDL Apo B-100 in patients with hypercholesterolemia and mixed hyperlipi... | |||
T17056 | Tetrahydrobiopterin | Sapropterin,BH4,(Rac)-Sapropterin | NOS , Endogenous Metabolite |
Tetrahydrobiopterin (BH4) is a cofactor for aromatic amino acid hydroxylases and an essential cofactor for nitric oxide synthase (NOS), which is used in the study of endothelial dysfunction such as hypertension, hypercho... | |||
T76739 | Bococizumab | RN316,PF-04950615 | Others |
Bococizumab(PF-04950615) is a humanized mAb against PCSK9 and an inhibitor of the synthesis of PCSK9 in the liver that reduces the amount of low-density lipoprotein cholesterol (LDL-C) in the blood.Bococizumab is used to... | |||
T76941 | Carotuximab | DE-122,TRC105 | TGF-beta/Smad , Immunology/Inflammation related |
Carotuximab (DE-122) is a novel endocholine antibody with strong antiangiogenic and anti-inflammatory activity. Carotuximab blocks endothelial glycoprotein (CD105) and its downstream Smad signaling pathway. Carotuximab h... | |||
T3874 | Diosgenin glucoside | Disogluside,Trillin | Apoptosis , Others , Autophagy |
Diosgenin glucoside (Trillin) and other synthetic glycosides with similar activities may be of use in the management of hypercholesterolemia and atherosclerosis. Significant inhibition of Diosgenin glucoside synthesis an... | |||
T30977 | Clofibride | ||
Clofibrin is a kind of hypolipidemic drug, which can reduce Hypertriglyceride and hypercholesterolemia. | |||
T27565 | Hyzetimibe | HS25,HS 25,HS-25 | |
Hyzetimibe, a cholesterol absorption blocker, is used potentially for the treatment of hypercholesterolemia. | |||
T28440 | PPD 10558 | PPD-10558,RBx10558,RBx-10558,PPD10558,RBx 10558 | |
PPD 10558, a HMG-CoA reductase inhibitor, is used potentially for treatment of primary hypercholesterolemia. | |||
T26182 | Seladelpar lysine | MBX-8025 lysine dihydrate,MBX-8025 Lysine,MBX 8025 Lysine MBX8025 Lysine | |
Seladelpar lysine, a selective PPAR-δ agonist, is used for the therapy of Homozygous Familial Hypercholesterolemia (HoFH). | |||
T27245 | (RS)-Eflucimibe | F12511,L-0081,F-12511,L0081 | |
Eflucimibe is an ACAT inhibitor. Eflucimibe regulates endogenous hypercholesterolemia in a synergistic manner in New Zealand rabbits fed a casein-enriched diet. In vivo, orally administered Eflucimibe displayed high pote... | |||
T81918 | Lodelcizumab | ||
Lodelcizumab, a monoclonal antibody, is utilized in the study of hypercholesterolemia [1]. | |||
T61430 | S-2E | ||
S-2E is a compound that functions as an orally active, noncompetitive inhibitor of both HMG-CoA reductase and acetyl-CoA carboxylase. It exhibits an anti-hyperlipidemic action, making it suitable for studying conditions ... | |||
T79052 | PCSK9-IN-16 | ||
PCSK9-IN-16, holds potential for research into hypercholesterolemia and other cardiovascular diseases [1]. | |||
T35724 | 4-hydroxy Atorvastatin (calcium salt) | ||
4-hydroxy Atorvastatin is a metabolite of atorvastatin , an HMG-CoA reductase inhibitor present in formulations that have been used to treat hypercholesterolemia and certain dyslipidemias. Atorvastatin is metabolized by ... |